Latest Blogs

Jan 19, 2023
Dr. Kathryn DeCarli and Dr. Jonathan Marron consider the actions an oncologist must, ought, and should take when offering professional medical interpretation services to a patient.
Dec 08, 2022
ASCO’s delegation to the American Medical Association’s House of Delegates (AMA HOD) recently traveled to Honolulu for the Interim meeting. Our resolutions primarily focused on the threat of legislation that could criminalize medically necessary care in the wake of the Supreme Court’s decision...
Dec 07, 2022
“Sitting here now, at 51 years old and as a cancer survivor of five years, the importance of self-care has become quite clear to me," writes Dr. Doug Flora.
Nov 28, 2022
I began my medical career in Arizona, where I received an early lesson in the importance of cultural sensitivity thanks to members of the Navajo Nation from the Four Corners region.
Subscribe to this column

Daniel F. Hayes, MD, FASCO, FACP

Daniel F. Hayes, MD, FACP, FASCO, is a Professor of Internal Medicine, the Stuart B. Padnos Professor in Breast Cancer, and the Clinical Director of the Breast Oncology Program at the University of Michigan Comprehensive Cancer Center. An ASCO member since 1986, Dr. Hayes has served the Society in numerous volunteer capacities, including as 2016-2017 ASCO President. He is involved in several ASCO Expert Panels related to breast cancer. He served on the ASCO Board of Directors from 2011-2014, on the Conquer Cancer Foundation Grants Selection Committee, as Chair of the Scientific Program Committee, and on the Journal of Clinical Oncology Editorial Board. In 2007, he was presented with ASCO’s Gianni Bonadonna Breast Cancer Award and Lecture; in 2013, he was elected as a Fellow of ASCO (FASCO). Follow Dr. Hayes on Twitter @hoosierdfh.

Apr 07, 2017
We’re making progress in better understanding, and communicating, the many issues surrounding adverse events, although not as fast as we’d like. In the long run, our patients will benefit from all of these initiatives.
Mar 31, 2017
Sustaining this progress described in this report will be determined in large part by the level of federal investment in our nation's biomedical research enterprise.
Mar 16, 2017
ASCO soundly opposes President Trump’s budget outline, which would cut $6 billion from the National Institutes of Health.
Mar 07, 2017
I am pleased to share the news that ASCO volunteers, staff, and collaborators are already making progress on major expansions to ASCO's programs to address global oncology priorities.
Jan 05, 2017
Do you belong to your ASCO State/Regional Affiliate? If not, you should! Do you take advantage of all they have to offer? If not, you should! You, and more importantly your patients, will benefit enormously.
Dec 22, 2016
The advent of rapid and relatively affordable high-throughput molecular analyses has permitted the development of a bewildering next generation of new cancer diagnostic tests that are being introduced into clinical care using our grandparents’ regulatory structure.

Pages